×
About 2,143 results

ALLMedicine™ Inflammatory Breast Cancer Center

Research & Reviews  1,005 results

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells.
https://doi.org/10.3791/62249
Journal of Visualized Experiments : JoVE; Hu X, Villodre ES et. al.

Feb 22nd, 2021 - Metastatic spread to the brain is a common and devastating manifestation of many types of cancer. In the United States alone, about 200,000 patients are diagnosed with brain metastases each year. Significant progress has been made in improving sur...

Evaluation of Breast Edema Findings at T2-weighted Breast MRI Is Useful for Diagnosing ...
https://doi.org/10.1148/radiol.2021202604
Radiology Harada TL, Uematsu T et. al.

Feb 9th, 2021 - Background Prediction of occult inflammatory breast cancer (IBC) and breast cancer prognosis based on breast edema findings on T2-weighted MRI scans, even for patients without clinical signs of IBC, would be useful in both pretreatment planning an...

Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SE...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868017
BMC Cancer; Jiao D, Zhang J et. al.

Feb 7th, 2021 - Previous studies have reported poor survival rates in inflammatory breast cancer (IBC) patients than non-inflammatory local advanced breast cancer (non-IBC) patients. However, until now, the survival rate of IBC and other T4 non-IBC (T4-non-IBC) p...

Estrogen receptor β-mediated inhibition of actin-based cell migration suppresses metast...
https://doi.org/10.1158/0008-5472.CAN-20-2743
Cancer Research; Thomas C, Karagounis IV et. al.

Jan 30th, 2021 - Inflammatory breast cancer (IBC) is a highly metastatic breast carcinoma with high frequency of estrogen receptor α (ER)α-negativity. Here we explored the role of the second ER subtype, ERβ, and report expression in IBC tumors and its correlation ...

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: AS...
https://doi.org/10.1200/JCO.20.03399
Journal of Clinical Oncology : Official Journal of the Am... Korde LA, Somerfield MR et. al.

Jan 28th, 2021 - To develop guideline recommendations concerning optimal neoadjuvant therapy for breast cancer. ASCO convened an Expert Panel to conduct a systematic review of the literature on neoadjuvant therapy for breast cancer and provide recommended care opt...

see more →

Guidelines  1 results

International expert panel on inflammatory breast cancer: consensus statement for stand...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3105293
Annals of Oncology : Official Journal of the European Soc... Dawood S, Merajver SD et. al.

Jul 6th, 2010 - Inflammatory breast cancer (IBC) represents the most aggressive presentation of breast cancer. Women diagnosed with IBC typically have a poorer prognosis compared with those diagnosed with non-IBC tumors. Recommendations and guidelines published t...

see more →

Clinicaltrials.gov  1,077 results

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells.
https://doi.org/10.3791/62249
Journal of Visualized Experiments : JoVE; Hu X, Villodre ES et. al.

Feb 22nd, 2021 - Metastatic spread to the brain is a common and devastating manifestation of many types of cancer. In the United States alone, about 200,000 patients are diagnosed with brain metastases each year. Significant progress has been made in improving sur...

Evaluation of Breast Edema Findings at T2-weighted Breast MRI Is Useful for Diagnosing ...
https://doi.org/10.1148/radiol.2021202604
Radiology Harada TL, Uematsu T et. al.

Feb 9th, 2021 - Background Prediction of occult inflammatory breast cancer (IBC) and breast cancer prognosis based on breast edema findings on T2-weighted MRI scans, even for patients without clinical signs of IBC, would be useful in both pretreatment planning an...

Comparison of survival in non-metastatic inflammatory and other T4 breast cancers: a SE...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868017
BMC Cancer; Jiao D, Zhang J et. al.

Feb 7th, 2021 - Previous studies have reported poor survival rates in inflammatory breast cancer (IBC) patients than non-inflammatory local advanced breast cancer (non-IBC) patients. However, until now, the survival rate of IBC and other T4 non-IBC (T4-non-IBC) p...

Estrogen receptor β-mediated inhibition of actin-based cell migration suppresses metast...
https://doi.org/10.1158/0008-5472.CAN-20-2743
Cancer Research; Thomas C, Karagounis IV et. al.

Jan 30th, 2021 - Inflammatory breast cancer (IBC) is a highly metastatic breast carcinoma with high frequency of estrogen receptor α (ER)α-negativity. Here we explored the role of the second ER subtype, ERβ, and report expression in IBC tumors and its correlation ...

Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: AS...
https://doi.org/10.1200/JCO.20.03399
Journal of Clinical Oncology : Official Journal of the Am... Korde LA, Somerfield MR et. al.

Jan 28th, 2021 - To develop guideline recommendations concerning optimal neoadjuvant therapy for breast cancer. ASCO convened an Expert Panel to conduct a systematic review of the literature on neoadjuvant therapy for breast cancer and provide recommended care opt...

see more →

News  41 results

Fast Five Quiz: Are You Prepared to Confront Metastatic Breast Cancer?
https://reference.medscape.com/viewarticle/870990_3

Aug 9th, 2020 - When PET is combined with CT scanning to assist in anatomic localization, scans can identify axillary and nonaxillary (eg, internal mammary or supraclavicular) lymph node metastasis for the purposes of staging locally advanced and inflammatory bre...

Idiopathic Granulomatous Mastitis
https://www.mdedge.com/dermatology/article/192305/mixed-topics/idiopathic-granulomatous-mastitis/page/0/1

Jan 8th, 2019 - Idiopathic granulomatous mastitis (IGM) is rare during pregnancy; it typically is seen in women of childbearing potential from 6 months to 6 years postpartum. 1 Because of a temporal association with breastfeeding, it is believed that hyperprolacti.

Diagnosing Inflammatory Breast Cancer: Can We Get Everyone on the Same Page?
https://www.medscape.com/viewarticle/901881

Sep 17th, 2018 - Hi. This is Dr Kathy Miller from Indiana University, back with you again. Today I want to talk a bit about inflammatory breast cancer. I'm willing to bet that a scene that played out at our local tumor board a couple of weeks ago will sound famili...

EGFR Inhibitor Shows Signal in Triple-Negative Inflammatory Breast Ca
https://www.medpagetoday.com/hematologyoncology/breastcancer/73398

Jun 8th, 2018 - Adding panitumumab to a carboplatin-containing neoadjuvant chemotherapy regimen yielded a higher rate of pathologic complete response (pCR) in patients with triple-negative inflammatory breast cancer (IBC), a small study found. Among the 17 evalua...

Late toxicities with PARP inhibitor plus RT in inflammatory breast cancer
https://www.mdedge.com/hematology-oncology/article/161606/breast-cancer/late-toxicities-parp-inhibitor-plus-rt-inflammatory/page/0/1

Mar 23rd, 2018 - The investigators noted that, at year 3, severe fibrosis in the treatment field was seen in 6 of the 15 surviving patients. Of the six patients, two also had grade 3 skin induration, and two had grade 3 lymphedema.

see more →

Patient Education  19 results see all →